Cargando…
Metabolic adverse events of multitarget kinase inhibitors: a systematic review
PURPOSE: Multitargeted kinase inhibitors (MKIs) are used for the treatment of several cancers. By targeting multiple signaling pathways, MKIs have become cornerstones of the oncologic treatment. Although their use leads to important results in terms of survival, treatment with MKIs can determine imp...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239378/ https://www.ncbi.nlm.nih.gov/pubmed/37067769 http://dx.doi.org/10.1007/s12020-023-03362-2 |